Antibiotic Opportunity? Spero’s Ankit Mahadevia on The Long Run Podcast Posted on August 8, 2018 at 10:00 am.Written by Spero Therapeutics Post navigation Boston-area companies bet on antibiotic development, even as big drug makers step backMeet the BBJ’s 2018 40 Under 40 honorees
